🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Book your place for the #PathLAKEPlus AI Showcase 20 Sept, launching rollout of AI tools to NHS cellular pathology workstreams. Thanks to our Sponsors Paige Ibex Medical Analytics Aiforia; HealthTrust Europe AIRA MATRIX Owkin @DeepMed_IO @ProsciaInc pathlake.org/event-pathlake…

Book now for the #PathLAKEPlus AI Showcase 20 Sept - launching rollout of AI tools into cellular pathology workstreams. Thanks to our Sponsors Paige, Ibex Medical Analytics, Aiforia; HealthTrust Europe, AIRA MATRIX, Owkin, @DeepMed_IO @ProsciaInc. pathlake.org/event-pathlake…

Institute for Precision Diagnostic & Translational Medicine #IPTDM next - where we’ve heard about exciting projects and opportunities in digital pathology, reproductive health, novel biomarkers, artificial intelligence and gastroenterology. #UHCWInstitutesforExcellence

Prof David Snead presents on PathLAKE and digital pathology algorithms improving diagnosis and outcomes for patients #IPSTM #UHCWInstitutesforExcellence

Less than a week away! Looking forward to joining PathLAKE, NHS pathologists, and the #digitalpathology community.

We are the silver sponsor for the PathLAKE Plus AI Showcase at University Hospitals, Coventry, UK. Connect with us at the AIRA Matrix booth to discuss AI solutions applicable in preanalytical and analytical digital pathology workflows. pathlake.org/event-pathlake…

We are honored to have been asked to demonstrate the power of AI for cancer detection and diagnosis at the PathLake Plus AI Showcase, where our COO Peter Hamilton will speak.

PathLAKE Plus AI Showcase workshops are in full swing with Paige Aiforia Ibex Medical Analytics demonstrating their AI tools for #digitalpathology

We've had a packed morning of presentations at the #PathLAKE Plus AI Showcase including an excellent keynote talk from Dr Colin Wilson

We enjoyed meeting you and sharing the power of our open, AI-ready Concentriq enterprise pathology platform at yesterday's AI Symposium. Thank you to PathLAKE Plus for hosting such an insightful event.

Members of our #WYAAT #pathology team joined the #PathLAKE AI event hosted by Coventry and Warwickshire Partnership NHS Trust. Presentations explored how AI and automation can be utilised to support clinical decision making and reduce time required for reporting digital images in cellular pathology.

📹 We're excited to be filming a video about the ARTICULATE PRO Study for patient and public information. First interview of the day: Professor Claire Verrill, the Project Lead. Visit the study website: nds.ox.ac.uk/research/verri…

Now for an exciting look into PathLAKE plus from Andrew White!

Congratulations to #PathLakePlus who has been nominated for two partnership awards at the #HSJPartnershipAwards2024 for Diagnostic Project of the Year and Most Effective Contribution to Improving Cancer Outcomes! PathLAKE

How can we use machine learning to cross-link #histopathology whole slide image patterns with underlying gene expression in cancer? Is it possible to achieve spatial mapping of expression from bulk transcriptomics? Our Cell Reports Medicine paper explores possibilitiesof #cpat for this?

We developed an ML pipeline to predict the gene expression profile of a cancer patient in the form of statuses of concomitant groups of genes with co-dependent expression from imaging for precision medicine and mining of histological patterns underlying transcriptomics.

Groups of genes with co-ordinated expression are first discovered using mutual information which allow us to capture the transcriptomic profile of a patient in terms of 200 binary gene group statuses that underpin cancer hallmark processes, pathways and diagnostic targets.

Link to the paper: cell.com/cell-reports-m… Online demo: tiademos.dcs.warwick.ac.uk/bokeh_app?demo… Image: Areas showing spatially localized status of Group 25.

Screening for breast, bowel and cervical cancer will be made quicker and more effective under plans to roll out the use of digital images to detect cancer. We're taking forward recommendations put forward by the UK National Screening Committee. Details: gov.uk/government/new…

COBIx: Multi-site validation study of the COBIx reporting tool. Registered at #ISRCTN by Warwick CTU PathLAKE @TIAwarwick @Histofy_ai isrctn.com/ISRCTN96000018 #clinicaltrials